PRODUÇÃO E AVALIAÇÃO NUTRICIONAL DE FARINHA DE MOYASHI - BROTO DE FEIJÃO MUNGO-VERDE (Vigna radiata, Fabaceae).

A Vigna radiata (L.) Wilczek popularmente conhecida como mungo-verde ou feijão-moyashi é um membro da família das leguminosas Fabaceae. Esta leguminosa é de fácil adaptação nos climas tropicais e subtropicais, sendo utilizada principalmente como suplemento proteico em diferentes pratos utilizando a farinha ou a leguminosa bruta, devido suas fontes de minerais, vitaminas, proteínas e baixas calorias o que o tornou popular no Brasil pela procura de alimentação saudável. Neste sentido, o objetivo do trabalho foi realizar uma avaliação química e  nutricional do broto de feijão-moyashi e da farinha produzida a partir dele. Para isso o alimento adquirido da Chácara Paraíso, passou inicialmente por uma análise macroscópica e foi submetido a várias determinações como: umidade, proteínas, lipídios, fibras e minerais, obtendo os seguintes resultados: 94,89%, 1,31%, 0,038%, 1,46% e 0,266%, respectivamente para o broto de feijão e 16,10%, 25,82%, 0,74%, 28,51% e 5,20%, para a farinha. Os dados de carboidratos foram obtido por diferença, 2,03% para o broto de feijão e 23,63% para a farinha. A partir dos dados obtidos comparou-se os resultados com os estabelecidos pela tabela TACO, e ainda com outras farinhas comerciais. Os valores nutricionais encontrados para o broto de feijão se mostraram próximos aos valores estabelecidos. Já a farinha do broto de feijão-moyashi se destacou pela grande quantidade de proteínas, baixo teor lipídico e grande quantidade de fibras, sendo assim, uma opção saudável para indivíduos veganos e vegetarianos por ser muito nutritiva e economicamente acessível

Is Previous Respiratory Disease a Risk Factor for Lung Cancer?

Rationale: Previous respiratory diseases have been associated with increased risk of lung cancer. Respiratory conditions often co-occur and few studies have investigated multiple conditions simultaneously. Objectives: Investigate lung cancer risk associated with chronic bronchitis, emphysema, tuberculosis, pneumonia, and asthma. Methods: The SYNERGY project pooled information on previous respiratory diseases from 12,739 case subjects and 14,945 control subjects from 7 case-control studies conducted in Europe and Canada. Multivariate logistic regression models were used to investigate the relationship between individual diseases adjusting for co-occurring conditions, and patterns of respiratory disease diagnoses and lung cancer. Analyses were stratified by sex, and adjusted for age, center, ever-employed in a high-risk occupation, education, smoking status, cigarette pack-years, and time since quitting smoking. Measurements and Main Results: Chronic bronchitis and emphysema were positively associated with lung cancer, after accounting for other respiratory diseases and smoking (e.g., in men: odds ratio [On 1.33; 95% confidence interval [CI], 1.20-1.48 and OR, 1.50; 95% CI, 1.21-1.87, respectively). A positive relationship was observed between. lung cancer and pneumonia diagnosed 2 years or less before lung cancer (OR, 3.31; 95% CI, 2.33-4.70 for men), but not longer. Co-occurrence of chronic bronchitis and emphysema and/or pneumonia had a stronger positive association with lung cancer than chronic bronchitis "only." Asthma had an inverse association with lung cancer, the association being stronger with an asthma diagnosis 5 years or more before lung cancer compared with shorter. Conclusions: Findings from this large international case-control consortium indicate that after accounting for co-occurring respiratory diseases, chronic bronchitis and emphysema continue to have a positive association with lung cancer. Keywords: epidemiologic study; lung neoplasm; pulmonary disease; data pooling; case-control stud

Randomized clinical trial of surgery versus conservative therapy for carpal tunnel syndrome [ISRCTN84286481]

BACKGROUND: Conservative treatment remains the standard of care for treating mild to moderate carpal tunnel syndrome despite a small number of well-controlled studies and limited objective evidence to support current treatment options. There is an increasing interest in the usefulness of wrist magnetic resonance imaging could play in predicting who will benefit for various treatments. METHOD AND DESIGN: Two hundred patients with mild to moderate symptoms will be recruited over 3 1/2 years from neurological surgery, primary care, electrodiagnostic clinics. We will exclude patients with clinical or electrodiagnostic evidence of denervation or thenar muscle atrophy. We will randomly assign patients to either a well-defined conservative care protocol or surgery. The conservative care treatment will include visits with a hand therapist, exercises, a self-care booklet, work modification/ activity restriction, B6 therapy, ultrasound and possible steroid injections. The surgical care would be left up to the surgeon (endoscopic vs. open) with usual and customary follow-up. All patients will receive a wrist MRI at baseline. Patients will be contacted at 3, 6, 9 and 12 months after randomization to complete the Carpal Tunnel Syndrome Assessment Questionnaire (CTSAQ). In addition, we will compare disability (activity and work days lost) and general well being as measured by the SF-36 version II. We will control for demographics and use psychological measures (SCL-90 somatization and depression scales) as well as EDS and MRI predictors of outcomes. DISCUSSION: We have designed a randomized controlled trial which will assess the effectiveness of surgery for patients with mild to moderate carpal tunnel syndrome. An important secondary goal is to study the ability of MRI to predict patient outcomes